Population PKPD modelling of the long‐term hypoglycaemic effect of gliclazide given as a once‐a‐day modified release (MR) formulation von Frey, N., Laveille, C., Paraire, M., Francillard, M., Holford, N. H. G., Jochemsen, Roeline

Volltext

Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: An 18 to 34-week, open-label, extension period von Moulin, P, André, M, Alawi, H, Dos Santos, L.C, Khalid, A.K, Koev, D, Moore, R, Serban, V, Picandet, B, Francillard, M

Volltext

High expression of the POU factor Brn3a in aggressive neuroendocrine tumors von LEBLOND-FRANCILLARD, M, PICON, A, BERTAGNA, X, DE KEYZER, Y

Volltext

Efficacy of Benfluorex in Combination With Sulfonylurea in Type 2 Diabetic Patients: An 18-week, randomized, double-blind study von Moulin, Philippe, Andre, Marie, Alawi, Hasan, dos Santos, Lelita C, Khalid, Abdul K, Koev, Dragomir, Moore, Ray, Serban, Viorel, Picandet, Brigitte, Francillard, Marie

Volltext

Loss of catalase activity in Tn1545-induced mutants does not reduce growth of Listeria monocytogenes in vivo von LEBLOND-FRANCILLARD, M, GAILLARD, J.-L, BERCHE, P

Volltext

Le secteur tertiaire dans le département de l'Isère von Veyret, Germaine, Marie, Christiane, Bravard, Yves, Morin, M.F., Francillard, M., Pellegrino, M., Mantes, M., Muet, M., Ozanne, M., Hasson, M., Meyssonnier, M.

Volltext

Isolation of DNA‐protein complexes based on streptavidin and biotin interaction von LEBLOND‐FRANCILLARD, Marie, DREYFUS, Marc, ROUGEON, François

Volltext

A mouse renin promoter containing the conserved decanucleotide element binds the same B-cell factors as an authentic immunoglobulin heavy chain promoter von Ekker, Marc, Doyen, Noelle, Leblond-Francillard, Marie, Rougeon, François

Volltext

Phaeochromocytoma as presenting manifestation of Von Hippel-Lindau disease von Richard, S, Resche, F, Vermesse, B, Fendler, J-P, Francillard, M, Laroche, F, Luton, J-P, M??ry, J-P, Proye, C, Redondo, A, Plouin, P-F

Volltext

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial von Verstovsek, Srdan, Vannucchi, Alessandro M, Griesshammer, Martin, Masszi, Tamas, Durrant, Simon, Passamonti, Francesco, Harrison, Claire N, Pane, Fabrizio, Zachee, Pierre, Kirito, Keita, Besses, Carlos, Hino, Masayuki, Moiraghi, Beatriz, Miller, Carole B, Cazzola, Mario, Rosti, Vittorio, Blau, Igor, Mesa, Ruben, Jones, Mark M, Zhen, Huiling, Li, Jingjin, Francillard, Nathalie, Habr, Dany, Kiladjian, Jean-Jacques

Volltext

Analysis of promoter and enhancer cell type specificities and the regulation of immunoglobulin gene expression von Doyen, Noëlle, Leblond-Francillard, Marie, Holm, Inge, Dreyfus, Marc, Rougeon, François

Volltext

Liver collagen mRNA and serum amino-terminal peptide of type III procollagen (PIIINP) levels in patients with alcoholic liver disease von Leblond-Francillard, Marie, Augereau, Christine, Nalpas, Bertrand, Trinchet, Jean-C., Hartmann, Daniel-J., Berthelot, Pierre, Beaugrand, Michel, Brechot, Christian

Volltext

Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study von Kiladjian, Jean-Jacques, Zachee, Pierre, Hino, Masayuki, Pane, Fabrizio, Masszi, Tamas, Harrison, Claire N, Mesa, Ruben, Miller, Carole B, Passamonti, Francesco, Durrant, Simon, Griesshammer, Martin, Kirito, Keita, Besses, Carlos, Moiraghi, Beatriz, Rumi, Elisa, Rosti, Vittorio, Blau, Igor Wolfgang, Francillard, Nathalie, Dong, Tuochuan, Wroclawska, Monika, Vannucchi, Alessandro M, Verstovsek, Srdan

Volltext

EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis von Vannucchi, Alessandro M, Te Boekhorst, Peter A W, Harrison, Claire N, He, Guangsheng, Caramella, Marianna, Niederwieser, Dietger, Boyer-Perrard, Françoise, Duan, Minghui, Francillard, Nathalie, Molloy, Betty, Wroclawska, Monika, Gisslinger, Heinz

Volltext

Long-Term Efficacy and Safety (5 Years) in RESPONSE, a Phase 3 Study Comparing Ruxolitinib (rux) with Best Available Therapy (BAT) in Hydroxyurea (HU)-Resistant/Intolerant Patients... von Kiladjian, Jean-Jacques, Zachée, Pierre, Hino, Masayuki, Pane, Fabrizio, Masszi, Tamas, Harrison, Claire N., Mesa, Ruben A., Miller, Carole B., Passamonti, Francesco, Durrant, Simon, Griesshammer, Martin, Kirito, Keita, Besses, Carles, Moiraghi, Beatriz, Rumi, Elisa, Rosti, Vittorio, Blau, Igor W., Francillard, Nathalie, Dong, Tuochuan, Wroclawska, Monika, Vannucchi, Alessandro M., Verstovsek, Srdan

Volltext

Results from the 208-Week (4-Year) Follow-up of RESPONSE Trial, a Phase 3 Study Comparing Ruxolitinib (Rux) with Best Available Therapy (BAT) for the Treatment of Polycythemia Vera... von Kiladjian, Jean-Jacques, Verstovsek, Srdan, Griesshammer, Martin, Masszi, Tamás, Durrant, Simon, Passamonti, Francesco, Harrison, Claire N., Pane, Fabrizio, Zachee, Pierre, Kirito, Keita, Besses, Carlos, Hino, Masayuki, Varela, Ana Ines, Miller, Carole B., Rumi, Elisa, Rosti, Vittorio, Blau, Igor Wolfgang, Mesa, Ruben A, Dong, Tuochuan, Francillard, Nathalie, Laughlin, Mary, Vannucchi, Alessandro M.

Volltext

Ruxolitinib in polycythemia vera: Follow-up from the RESPONSE trial von Verstovsek, Srdan, Vannucchi, Alessandro M., Griesshammer, Martin, Masszi, Tamás, Durrant, Simon, Passamonti, Francesco, Harrison, Claire N., Pane, Fabrizio, Zachee, Pierre, Hino, Masayuki, Moiraghi, Beatriz, Miller, Carole Brennan, Rosti, Vittorio, Mesa, Ruben A., Jones, Mark M., Zhen, Huiling, Li, Jingjin, Francillard, Nathalie, Habr, Dany, Kiladjian, Jean-Jacques

Volltext

Detection of Human and Animal Rotavirus Sequences in Drinking Water von Gratacap-Cavallier, B, Genoulaz, O, Brengel-Pesce, K, Soule, H, Innocenti-Francillard, P, Bost, M, Gofti, L, Zmirou, D, Seigneurin, J M

Volltext

Heat stress‐induced B1 receptor synthesis in the rat: an ex vivo study von Lagneux, Caroline, Innocenti‐Francillard, Patricia, Godin‐Ribuot, Diane, Bader, Mickael, Ribuot, Christophe

Volltext

Rôle d’IGF2 dans la croissance des cortico-surrénalomes : comparaison des tumeurs et de cellules H295R exprimant ou non-IGF2 von Guillaud-Bataille, M, De Reynies, M.A, Ragazzon, B, Barreau, O, Francillard, I, Rizk-Rabin, M, Chevallier, C, Guillemot, J, Tissier, F, René-Corail, F, Assie, G, Bertagna, X, Baudin, E, Bertherat, J, Clauser, E

Volltext